Inventor · disambiguated record
Kishor Devalaraja-Narashimha
Also filed as: DEVALARAJA-NARASHIMHA KISHOR
3 granted patents·7 pending applications·2 citations·filing 2018–2025
53Inventor score
Files withREGENERON PHARMA10
Top patents by PatentIndex Score
10 records- 0173US10765762B2Humanized model of kidney and liver disordersREGENERON PHARMA·Filed 2018·Granted Sep 8, 2020·2 cites·16 claims
- 0273US2024392039A1Anti-c5 antibodies combinations and uses thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0370US2025154487A1Engineered alpha klotho polypeptides and uses thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0469US12084516B2Anti-C5 antibody combinations and uses thereofREGENERON PHARMA·Filed 2022·Granted Sep 10, 2024·0 cites·15 claims
- 0564US2024158795A1Treatment Of Kidney Diseases With A Combination of Angiopoietin Like 3 (ANGPTL3) Inhibitors And Solute Carrier Family 5 Member 2 (SLC5A2) InhibitorsREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0661US2023193271A1Treatment Of Kidney Diseases With Angiopoietin Like 3 (ANGPTL3) InhibitorsREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0758US11365265B2Anti-C5 antibody combinations and uses thereofREGENERON PHARMA·Filed 2018·Granted Jun 21, 2022·0 cites·16 claims
- 0857US2024415980A1Crispr/cas-related methods and compositions for knocking out c5REGENERON PHARMA·Filed 2022·Application pending·0 cites
- 0955US2025376667A1Engineered alpha klotho polypeptides and uses thereofREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1052US2022053741A1Complement Factor H Gene Knockout Rat as a Model of C3 GlomerulopathyREGENERON PHARMA·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kishor Devalaraja-Narashimha files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →